The Utilization of Lipid-Lowering Drugs and Participation in the German Disease Management Program for Coronary Artery Disease in Patients With Atherosclerotic Disease: An Analysis of Claims Data.
- DOI
- 10.3238/arztebl.m2026.0022
- Published
- 2026 Apr 17
- Container
- Deutsches Arzteblatt international
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3238/arztebl.m2026.0022,
title = {The Utilization of Lipid-Lowering Drugs and Participation in the German Disease Management Program for Coronary Artery Disease in Patients With Atherosclerotic Disease: An Analysis of Claims Data.},
author = {Kogel A and Müller LM and Krampe J and Laufs U and Katzmann JL},
year = {2026},
journal = {Deutsches Arzteblatt international},
doi = {10.3238/arztebl.m2026.0022},
url = {https://doi.org/10.3238/arztebl.m2026.0022}
}RIS
TY - JOUR TI - The Utilization of Lipid-Lowering Drugs and Participation in the German Disease Management Program for Coronary Artery Disease in Patients With Atherosclerotic Disease: An Analysis of Claims Data. AU - Kogel A AU - Müller LM AU - Krampe J AU - Laufs U AU - Katzmann JL PY - 2026 JO - Deutsches Arzteblatt international DO - 10.3238/arztebl.m2026.0022 UR - https://doi.org/10.3238/arztebl.m2026.0022 ER -
APA
A, K., LM, M., J, K., U, L., & JL, K. (2026). The Utilization of Lipid-Lowering Drugs and Participation in the German Disease Management Program for Coronary Artery Disease in Patients With Atherosclerotic Disease: An Analysis of Claims Data.. Deutsches Arzteblatt international. https://doi.org/10.3238/arztebl.m2026.0022
Source records
- pubmed · retrieved 2026-09-27T10:14:30.391Z